홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Phosphate, Tribasic → 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline

HRID 2172292
인쇄

반응식

HRID 2172292 반응식
Cl.Br[C:3]1[CH:12]=[CH:11][CH:10]=[C:9]2[C:4]=1[CH2:5][CH2:6][NH:7][CH2:8]2.[CH3:13][N:14]1[C:18]([C:19]2[CH:24]=[C:23]([C:25]([F:28])([F:27])[F:26])[CH:22]=[CH:21][C:20]=2B(O)O)=[CH:17][CH:16]=[N:15]1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>>[CH3:13][N:14]1[C:18]([C:19]2[CH:24]=[C:23]([C:25]([F:26])([F:27])[F:28])[CH:22]=[CH:21][C:20]=2[C:3]2[CH:12]=[CH:11][CH:10]=[C:9]3[C:4]=2[CH2:5][CH2:6][NH:7][CH2:8]3)=[CH:17][CH:16]=[N:15]1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 62657Potassium Phosphate, TribasicHCID 450740035-Bromo-1,2,3,4-tetrahydroisoquinoline hydrochlorideHCID 71258947(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)boronic acid2회

생성물 1

HCID 898152865-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline

반응 조건

온도
90 °C

실험 절차

A vial was charged with 5-bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride (ASW Medchem, Brunswick, N.J., 400.42 mg, 1.367 mmol), (2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)boronic acid (Intermediate B, 443 mg, 1.640 mmol), potassium phosphate (1160 mg, 5.47 mmol), and Pd(AmPhos)2Cl2 (Sigma-Aldrich, St. Louis, Mo., 48.4 mg, 0.068 mmol). The vial was flushed with Ar (g), then dioxane (2928 μl) and water (976 μl) were added in sequence. The mixture was heated in a microwave reactor for 30 min at 90° C. After cooling to room temperature, the mixture was diluted with EtOAc, washed with water (and a small amount of brine to break up emulsions, 2×), washed with brine, dried over sodium sulfate, filtered, and concentrated. The residue was taken up in MeOH, then loaded onto a 10 g SCX-2 ion exchange column. The column was eluted with MeOH, then with 2M ammonia in MeOH. The basic filtrate was concentrated, and the residue was chromatographed on a 40 g silica gel column with 0 to 10% MeOH/DCM to provide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline as a pale yellow solid. [M+H]+=358.1. 1H NMR (400 MHz, DMSO-d6) δ ppm=7.91-7.80 (m, 2H), 7.56 (d, J=8.0 Hz, 1H), 7.28 (d, J=2.0 Hz, 1H), 7.09-6.95 (m, 2H), 6.84 (dd, J=1.3, 7.4 Hz, 1H), 5.96 (d, J=1.9 Hz, 1H), 3.85 (s, 2H), 3.52 (br. s., 3H), 2.93-2.84 (m, 1H), 2.79-2.67 (m, 1H), 2.48-2.39 (m, 1H), 2.09 (td, J=5.3, 16.7 Hz, 1H).

후처리

  1. customThe vial was flushed with Ar (g)
  2. additiondioxane (2928 μl) and water (976 μl) were added in sequence
  3. temperatureAfter cooling to room temperature
  4. additionthe mixture was diluted with EtOAc
  5. washwashed with water (and a small amount of brine
  6. washwashed with brine
  7. dry with materialdried over sodium sulfate
  8. filtrationfiltered
  9. concentrationconcentrated
  10. washThe column was eluted with MeOH
  11. concentrationThe basic filtrate was concentrated
  12. customthe residue was chromatographed on a 40 g silica gel column with 0 to 10% MeOH/DCM

출처 및 근거

ORD 기록
ord-e9ba0b39e7304097bb78aa7b325bc534
출처 데이터셋
uspto-grants-2015_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09051311B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트